Nu Skin Enterprises, Inc. (NUS)
NYSE: NUS · Real-Time Price · USD
4.030
+0.020 (0.50%)
At close: Nov 13, 2026, 4:00 PM EST
4.040
+0.010 (0.25%)
After-hours: Nov 13, 2026, 7:34 PM EST
Nu Skin Enterprises Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,322 | 1,485 | 1,732 | 1,969 | 2,226 | 2,696 | |
Revenue Growth | -15.28% | -14.26% | -12.04% | -11.53% | -17.44% | 4.41% |
Cost of Revenue | 425.11 | 453.76 | 511.43 | 546.15 | 604.02 | 675.22 |
Gross Profit | 896.94 | 1,031 | 1,221 | 1,423 | 1,622 | 2,020 |
Selling, General & Admin | 843.18 | 940.52 | 1,131 | 1,289 | 1,435 | 1,735 |
Operating Expenses | 843.18 | 940.52 | 1,131 | 1,289 | 1,435 | 1,735 |
Operating Income | 53.75 | 90.88 | 89.58 | 133.76 | 186.24 | 285.86 |
Interest Expense | -15.07 | -13.95 | -26.41 | -25.56 | -13.49 | -11 |
Other Non Operating Income (Expenses) | -26.55 | -31.78 | 2.94 | 3.87 | -8.38 | -8.61 |
EBT Excluding Unusual Items | 12.14 | 45.15 | 66.11 | 112.07 | 164.36 | 266.25 |
Merger & Restructuring Charges | -1.8 | -25.11 | -38.8 | -85.49 | -75.39 | -51.87 |
Impairment of Goodwill | -78.88 | - | -134.5 | - | - | - |
Gain (Loss) on Sale of Investments | 28.08 | - | - | - | - | 18.08 |
Gain (Loss) on Sale of Assets | - | 176.16 | - | - | - | - |
Asset Writedown | -0.04 | - | -67.86 | - | - | - |
Pretax Income | -40.5 | 196.2 | -175.05 | 26.58 | 88.97 | 232.46 |
Income Tax Expense | 193.72 | 35.99 | -28.46 | 17.98 | -15.81 | 85.19 |
Net Income | -234.21 | 160.2 | -146.59 | 8.6 | 104.78 | 147.27 |
Net Income to Common | -234.21 | 160.2 | -146.59 | 8.6 | 104.78 | 147.27 |
Net Income Growth | - | - | - | -91.80% | -28.85% | -23.04% |
Shares Outstanding (Basic) | 49 | 49 | 50 | 50 | 50 | 50 |
Shares Outstanding (Diluted) | 49 | 50 | 50 | 50 | 51 | 51 |
Shares Change | -3.06% | 1.29% | -0.40% | -1.32% | -1.75% | -2.54% |
EPS (Basic) | -4.83 | 3.25 | -2.95 | 0.17 | 2.10 | 2.93 |
EPS (Diluted) | -4.84 | 3.18 | -2.95 | 0.17 | 2.07 | 2.86 |
EPS Growth | - | - | - | -91.79% | -27.62% | -21.21% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -26.26 | 46.01 | 70.16 | 60.15 | 49.01 | 72.97 |
Free Cash Flow Per Share | -0.54 | 0.92 | 1.41 | 1.21 | 0.97 | 1.42 |
Dividend Per Share | 0.240 | 0.240 | 0.240 | 1.560 | 1.540 | 1.520 |
Dividend Growth | 0% | 0% | -84.61% | 1.30% | 1.32% | 1.33% |
Gross Margin | 67.84% | 69.45% | 70.47% | 72.26% | 72.86% | 74.95% |
Operating Margin | 4.07% | 6.12% | 5.17% | 6.79% | 8.37% | 10.60% |
Profit Margin | -17.72% | 10.79% | -8.46% | 0.44% | 4.71% | 5.46% |
Free Cash Flow Margin | -1.99% | 3.10% | 4.05% | 3.06% | 2.20% | 2.71% |
EBITDA | 104.2 | 143.14 | 159.39 | 204.68 | 258.75 | 362.18 |
EBITDA Margin | 7.88% | 9.64% | 9.20% | 10.39% | 11.63% | 13.44% |
D&A For EBITDA | 50.45 | 52.26 | 69.81 | 70.92 | 72.51 | 76.32 |
EBIT | 53.75 | 90.88 | 89.58 | 133.76 | 186.24 | 285.86 |
EBIT Margin | 4.07% | 6.12% | 5.17% | 6.79% | 8.37% | 10.60% |
Effective Tax Rate | - | 18.34% | - | 67.66% | - | 36.65% |
Advertising Expenses | - | 19 | 17.4 | 18 | 14.5 | 15.5 |